Shanghai Henlius Biotech, Inc. (2696.HK) - Stock Prices, Stock Peers & Analysis

Home
2696.HK

Company Name	Shanghai Henlius Biotech, Inc.
Symbol	2696.HK
Currency	HKD
Price	23.15
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	12,581,905,685
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	9.6 - 23.45
Industry	Biotechnology
Sector	Healthcare
CEO	Mr. Jun Zhu
Website	https://www.henlius.com

An error occurred while fetching data.

About Shanghai Henlius Biotech, Inc.

Shanghai Henlius Biotech, Inc., a biopharmaceutical company, engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases. It offers HANLIKANG, a rituximab injection for treating non-hodgkin lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis; HANQUYOU, a trastuzumab injection to treat breast and